Money Talk

Syngene targets delivering 500,000 vials of Remdesivir in India as COVID-19 surges

Syngene targets delivering 500,000 vials of Remdesivir in India as COVID-19 surges “At the moment we are operating at near maximum capacity (to produce remdesivir),” Chief Executive Officer Jonathan Hunt told Reuters on Wednesday.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s